Capital Structure HeartWare presently has 8,866,702 shares of common stock on issue and these are represented by 309,092,210 CDI’s which are tradeable on the ASX (being a ratio of one share of common stock to 35 CDI’s). Following listing on NASDAQ, it is expected that some investors, particularly our US investors, will migrate their holdings from Australia to the United States by exchanging their CDI’s for common stock. In this regard, HeartWare’s stock is very tightly held with approximately 80% of the shares being held by investors located in the United States. Our four largest shareholders, Apple Tree Partners, Muneer Satter, Fidelity Investments and Deephaven Capital Management, account for approximately 60% of HeartWare’s issued capital. The remaining 20% of US-owned stock is held primarily by specialist healthcare funds including Eaton Vance, Redmile Group, Broadfin Capital and others. US investor interest in the HeartWare story continues to grow. HeartWare believes that listing on NASDAQ will help to deepen the already strong institutional presence on the Company’s share register.
HTW Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held
